Paras Defence and Space Technologies Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 29, 2025, 7:39 pm

Quick Insight

Paras Defence and Space Technologies Ltd's current intrinsic value and share price analysis reveals a price of 652 with a market capitalization of 5,253 Cr. Despite a high P/E ratio of 81.3, the company demonstrates a respectable ROE of 11.8% and ROCE of 16.6%. Operating profit margin stands at a healthy 25%, with net profit at 65 Cr. While details on specific shareholders are not available, the company holds significant reserves of 603 Cr and minimal borrowings at ₹1 Cr, indicating a strong financial position. With a current P/BV of 6.03x and an interest coverage ratio of 15.88x, Paras Defence shows potential for growth and stability in the Aerospace & Defense industry.

Competitors of Paras Defence and Space Technologies Ltd

All Competitor Stocks of Paras Defence and Space Technologies Ltd

Quarterly Result

Last Updated: August 1, 2025, 7:50 am

Below is a detailed analysis of the quarterly data for Paras Defence and Space Technologies Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 87.00 Cr.. The value appears to be declining and may need further review. It has decreased from 90.00 Cr. (Mar 2025) to 87.00 Cr., marking a decrease of 3.00 Cr..
• For Expenses, as of Jun 2025, the value is 66.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 67.00 Cr. (Mar 2025) to 66.00 Cr., marking a decrease of 1.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 22.00 Cr.. The value appears to be declining and may need further review. It has decreased from 23.00 Cr. (Mar 2025) to 22.00 Cr., marking a decrease of 1.00 Cr..
• For OPM %, as of Jun 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00%.
• For Other Income, as of Jun 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 2.00 Cr..
• For Interest, as of Jun 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 2.00 Cr..
• For Depreciation, as of Jun 2025, the value is 4.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.00 Cr. (Mar 2025) to 4.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 21.00 Cr.. The value appears to be declining and may need further review. It has decreased from 23.00 Cr. (Mar 2025) to 21.00 Cr., marking a decrease of 2.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00%.
• For Net Profit, as of Jun 2025, the value is 15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 17.00 Cr. (Mar 2025) to 15.00 Cr., marking a decrease of 2.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.91. The value appears to be declining and may need further review. It has decreased from 2.11 (Mar 2025) to 1.91, marking a decrease of 0.20.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:35 pm

Balance Sheet

Last Updated: July 25, 2025, 1:54 pm

Below is a detailed analysis of the balance sheet data for Paras Defence and Space Technologies Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 40.00 Cr.. The value appears strong and on an upward trend. It has increased from 39.00 Cr. (Mar 2024) to 40.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 603.00 Cr.. The value appears strong and on an upward trend. It has increased from 408.00 Cr. (Mar 2024) to 603.00 Cr., marking an increase of 195.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 35.00 Cr. (Mar 2024) to 1.00 Cr., marking a decrease of 34.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 187.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 126.00 Cr. (Mar 2024) to 187.00 Cr., marking an increase of 61.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 831.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 608.00 Cr. (Mar 2024) to 831.00 Cr., marking an increase of 223.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 178.00 Cr.. The value appears strong and on an upward trend. It has increased from 173.00 Cr. (Mar 2024) to 178.00 Cr., marking an increase of 5.00 Cr..
• For CWIP, as of Mar 2025, the value is 7.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2024) to 7.00 Cr., marking an increase of 3.00 Cr..
• For Investments, as of Mar 2025, the value is 39.00 Cr.. The value appears strong and on an upward trend. It has increased from 31.00 Cr. (Mar 2024) to 39.00 Cr., marking an increase of 8.00 Cr..
• For Other Assets, as of Mar 2025, the value is 608.00 Cr.. The value appears strong and on an upward trend. It has increased from 400.00 Cr. (Mar 2024) to 608.00 Cr., marking an increase of 208.00 Cr..
• For Total Assets, as of Mar 2025, the value is 831.00 Cr.. The value appears strong and on an upward trend. It has increased from 608.00 Cr. (Mar 2024) to 831.00 Cr., marking an increase of 223.00 Cr..

Notably, the Reserves (603.00 Cr.) exceed the Borrowings (1.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Paras Defence and Space Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 16.02. This value is within the healthy range. It has increased from 8.22 (Mar 24) to 16.02, marking an increase of 7.80.
• For Diluted EPS (Rs.), as of Mar 25, the value is 16.02. This value is within the healthy range. It has increased from 8.22 (Mar 24) to 16.02, marking an increase of 7.80.
• For Cash EPS (Rs.), as of Mar 25, the value is 18.96. This value is within the healthy range. It has increased from 11.14 (Mar 24) to 18.96, marking an increase of 7.82.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 158.83. It has increased from 102.93 (Mar 24) to 158.83, marking an increase of 55.90.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 158.83. It has increased from 113.66 (Mar 24) to 158.83, marking an increase of 45.17.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 90.51. It has increased from 65.00 (Mar 24) to 90.51, marking an increase of 25.51.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 26.09. This value is within the healthy range. It has increased from 15.21 (Mar 24) to 26.09, marking an increase of 10.88.
• For PBIT / Share (Rs.), as of Mar 25, the value is 22.39. This value is within the healthy range. It has increased from 11.79 (Mar 24) to 22.39, marking an increase of 10.60.
• For PBT / Share (Rs.), as of Mar 25, the value is 20.74. This value is within the healthy range. It has increased from 10.39 (Mar 24) to 20.74, marking an increase of 10.35.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 15.25. This value is within the healthy range. It has increased from 7.72 (Mar 24) to 15.25, marking an increase of 7.53.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 15.75. This value is within the healthy range. It has increased from 8.22 (Mar 24) to 15.75, marking an increase of 7.53.
• For PBDIT Margin (%), as of Mar 25, the value is 28.82. This value is within the healthy range. It has increased from 23.40 (Mar 24) to 28.82, marking an increase of 5.42.
• For PBIT Margin (%), as of Mar 25, the value is 24.73. This value exceeds the healthy maximum of 20. It has increased from 18.13 (Mar 24) to 24.73, marking an increase of 6.60.
• For PBT Margin (%), as of Mar 25, the value is 22.91. This value is within the healthy range. It has increased from 15.98 (Mar 24) to 22.91, marking an increase of 6.93.
• For Net Profit Margin (%), as of Mar 25, the value is 16.85. This value exceeds the healthy maximum of 10. It has increased from 11.87 (Mar 24) to 16.85, marking an increase of 4.98.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 17.40. This value is within the healthy range. It has increased from 12.64 (Mar 24) to 17.40, marking an increase of 4.76.
• For Return on Networth / Equity (%), as of Mar 25, the value is 9.91. This value is below the healthy minimum of 15. It has increased from 7.95 (Mar 24) to 9.91, marking an increase of 1.96.
• For Return on Capital Employeed (%), as of Mar 25, the value is 13.64. This value is within the healthy range. It has increased from 9.80 (Mar 24) to 13.64, marking an increase of 3.84.
• For Return On Assets (%), as of Mar 25, the value is 7.44. This value is within the healthy range. It has increased from 5.01 (Mar 24) to 7.44, marking an increase of 2.43.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.03. This value is within the healthy range. It has decreased from 0.16 (Mar 24) to 0.03, marking a decrease of 0.13.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.48. It has increased from 0.43 (Mar 24) to 0.48, marking an increase of 0.05.
• For Current Ratio (X), as of Mar 25, the value is 3.13. This value exceeds the healthy maximum of 3. It has increased from 2.35 (Mar 24) to 3.13, marking an increase of 0.78.
• For Quick Ratio (X), as of Mar 25, the value is 2.34. This value exceeds the healthy maximum of 2. It has increased from 1.47 (Mar 24) to 2.34, marking an increase of 0.87.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 4. It has decreased from 1.04 (Mar 24) to 0.84, marking a decrease of 0.20.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 15.88. This value is within the healthy range. It has increased from 10.91 (Mar 24) to 15.88, marking an increase of 4.97.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 10.28. This value is within the healthy range. It has increased from 6.53 (Mar 24) to 10.28, marking an increase of 3.75.
• For Enterprise Value (Cr.), as of Mar 25, the value is 3,769.73. It has increased from 2,438.85 (Mar 24) to 3,769.73, marking an increase of 1,330.88.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 10.34. This value exceeds the healthy maximum of 3. It has increased from 9.62 (Mar 24) to 10.34, marking an increase of 0.72.
• For EV / EBITDA (X), as of Mar 25, the value is 35.86. This value exceeds the healthy maximum of 15. It has decreased from 41.11 (Mar 24) to 35.86, marking a decrease of 5.25.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 10.59. This value exceeds the healthy maximum of 3. It has increased from 9.42 (Mar 24) to 10.59, marking an increase of 1.17.
• For Price / BV (X), as of Mar 25, the value is 6.03. This value exceeds the healthy maximum of 3. It has increased from 5.93 (Mar 24) to 6.03, marking an increase of 0.10.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 10.59. This value exceeds the healthy maximum of 3. It has increased from 9.42 (Mar 24) to 10.59, marking an increase of 1.17.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness